Scholarlink

<p>This study presents the design, development, and characterization of pH-responsive hydrogels and hydrogel nanocomposites (HNCs) tailored for the safe oral delivery of insulin. A number of formulations of the aforementioned networks were developed utilizing acrylic acid and methacrylic acid (monomers) and a crosslinker in variable amounts. Swelling investigations confirmed minimal expansion at acidic pH (1.2) and significant swelling at physiological pH (7.4), aligning with controlled insulin release in the intestinal environment. Concentration variations of monomers and crosslinkers influenced swelling (89.45–98.5%), gel fraction (82.47–98.34%), and loading efficiency (69.98–97.63%). Fourier transform infrared spectroscopy (FTIR) validated the successful formation of grafts and safe loading of insulin. Morphological analysis using scanning electron microscopy (SEM) revealed that surface variations were influenced by the inclusion of Ins-Mmt nanoclay. X-ray diffraction (PXRD) studies indicated that the optimized formulation retains the physical form of insulin. Thermal investigations (DSC and TGA) demonstrated enhanced thermal stability in the case of HNCs. Energy-dispersive X-ray spectroscopy (EDX) confirmed the effective incorporation of the insulin–montmorillonite nanoclay (Ins-Mmt) complex within the hydrogel. Release studies indicated controlled and pH-responsive insulin release (72.52–94.52%, up to 24&#xa0;h), with kinetic modeling fitting the Korsmeyer–Peppas model, suggesting non-Fickian diffusion. Based on the release kinetics, the Ins-Mmt complex containing linseed and acrylic acid-based hydrogel formulation (Ins-Mmt-LA6) was considered the optimized formulation. This comprehensive characterization establishes the potential of these formulations for pH-responsive and safe oral insulin delivery, offering insights for future advancements in controlled drug release systems.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Linseed-based hydrogel nanocomposites for pH-responsive and controlled insulin delivery: design, characterization, and in vitro kinetic analysis

  • 期刊论文

  • 发表日期：

    2025年7月7日

查看全文
  • Farya Shabir,
  • Asif Mahmood,
  • Muhammad Zaman,
  • Rai Muhammad Sarfraz,
  • Abir Boublia,
  • Hira Ijaz,
  • Muhammad Rouf Akram,
  • Ayesha Mahmood,
  • Barbara Ernst,
  • Mohammad Raish,
  • Yacine Benguerba

摘要

This study presents the design, development, and characterization of pH-responsive hydrogels and hydrogel nanocomposites (HNCs) tailored for the safe oral delivery of insulin. A number of formulations of the aforementioned networks were developed utilizing acrylic acid and methacrylic acid (monomers) and a crosslinker in variable amounts. Swelling investigations confirmed minimal expansion at acidic pH (1.2) and significant swelling at physiological pH (7.4), aligning with controlled insulin release in the intestinal environment. Concentration variations of monomers and crosslinkers influenced swelling (89.45–98.5%), gel fraction (82.47–98.34%), and loading efficiency (69.98–97.63%). Fourier transform infrared spectroscopy (FTIR) validated the successful formation of grafts and safe loading of insulin. Morphological analysis using scanning electron microscopy (SEM) revealed that surface variations were influenced by the inclusion of Ins-Mmt nanoclay. X-ray diffraction (PXRD) studies indicated that the optimized formulation retains the physical form of insulin. Thermal investigations (DSC and TGA) demonstrated enhanced thermal stability in the case of HNCs. Energy-dispersive X-ray spectroscopy (EDX) confirmed the effective incorporation of the insulin–montmorillonite nanoclay (Ins-Mmt) complex within the hydrogel. Release studies indicated controlled and pH-responsive insulin release (72.52–94.52%, up to 24 h), with kinetic modeling fitting the Korsmeyer–Peppas model, suggesting non-Fickian diffusion. Based on the release kinetics, the Ins-Mmt complex containing linseed and acrylic acid-based hydrogel formulation (Ins-Mmt-LA6) was considered the optimized formulation. This comprehensive characterization establishes the potential of these formulations for pH-responsive and safe oral insulin delivery, offering insights for future advancements in controlled drug release systems.